PERTH, Australia, March 21 /PRNewswire/ -- Ozgene Pty Ltd (Perth, Australia) announced this week that it has reached a final milestone in one it's drug target validation projects for NV Organon (The Netherlands).
This milestone marks the successful completion of the first project out of a series of studies undertaken between Ozgene and Organon.
The contact research undertaken by Ozgene will form the basis for further studies by the Dutch pharmaceutical company.
"We are very excited to deliver these results to Organon and are looking forward to the continuing collaboration between Ozgene and Organon" commented Dr Frank Koentgen (Director and CEO of Ozgene).
"We are happy with the progress achieved and look forward to the results of our cooperation with Ozgene" said Ton Rijnders, VP Research, N.V. Organon.
Business Development Office
Ozgene Pty Ltd
CONTACT: Business Development Office, email: email@example.com, tel:+61-8-9212-2200